Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shining Wang

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Molecular Cancer Therapeutics|June 11, 2009
Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinibShining Wang, Qingyu Zhou, James M Gallo
Isotopes in Environmental and Health Studies|January 25, 2024
Origin and stability of pit lake water in Baiyinhua, Inner Mongolia, based on hydrochemistry and stable isotopesShengliang Pei, Deqiang Zhang, Shining Wang, et al.
Drug Delivery|January 21, 2006
A new bioimaging carrier for fluorescent quantum dots: phospholipid nanoemulsion mimicking natural lipoprotein coreSuwen Liu, Clement M Lee, Shining Wang, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2024
Generating ESC-Derived RGCs for Cell Replacement TherapyMishal Rao, Chia-Chun Liu, Shining Wang, et al.
Journal of Clinical Pharmacology|October 30, 2022
Population Pharmacokinetics of Mivavotinib (TAK-659), a Dual Spleen Tyrosine Kinase and FMS-Like Tyrosine Kinase 3 Inhibitor, in Patients With Advanced Solid Tumors or Hematologic MalignanciesCheryl Li, Kenny Watson, Shining Wang, et al.
Molecular Cancer Therapeutics|February 19, 2008
Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor modelsShining Wang, Ping Guo, Xiaomin Wang, et al.
Clinical Pharmacology in Drug Development|February 7, 2026
Clinical Significance of IL-4 and IL-21 Concurrent Elevation in Predicting Disease Activity Score and Antihistamine Treatment Response in Chronic Spontaneous UrticariaShining Wang, Xiaojing Yang, Xuming Zhao, et al.
Briefings in Bioinformatics|February 21, 2022
Adapt-Kcr: a novel deep learning framework for accurate prediction of lysine crotonylation sites based on learning embedding features and attention architectureZutan Li, Jingya Fang, Shining Wang, et al.
Immunity, Inflammation and Disease|July 28, 2023
The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patientsXiaojing Yang, Leigang Chen, Shining Wang, et al.
British Journal of Clinical Pharmacology|April 10, 2021
Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjectsShining Wang, Grace Chen, Emilio Merlo Pich, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|June 11, 2009
Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinibShining Wang, Qingyu Zhou, James M Gallo
Isotopes in Environmental and Health Studies|January 25, 2024
Origin and stability of pit lake water in Baiyinhua, Inner Mongolia, based on hydrochemistry and stable isotopesShengliang Pei, Deqiang Zhang, Shining Wang, et al.
Drug Delivery|January 21, 2006
A new bioimaging carrier for fluorescent quantum dots: phospholipid nanoemulsion mimicking natural lipoprotein coreSuwen Liu, Clement M Lee, Shining Wang, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2024
Generating ESC-Derived RGCs for Cell Replacement TherapyMishal Rao, Chia-Chun Liu, Shining Wang, et al.
Journal of Clinical Pharmacology|October 30, 2022
Population Pharmacokinetics of Mivavotinib (TAK-659), a Dual Spleen Tyrosine Kinase and FMS-Like Tyrosine Kinase 3 Inhibitor, in Patients With Advanced Solid Tumors or Hematologic MalignanciesCheryl Li, Kenny Watson, Shining Wang, et al.
Molecular Cancer Therapeutics|February 19, 2008
Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor modelsShining Wang, Ping Guo, Xiaomin Wang, et al.
Clinical Pharmacology in Drug Development|February 7, 2026
Clinical Significance of IL-4 and IL-21 Concurrent Elevation in Predicting Disease Activity Score and Antihistamine Treatment Response in Chronic Spontaneous UrticariaShining Wang, Xiaojing Yang, Xuming Zhao, et al.
Briefings in Bioinformatics|February 21, 2022
Adapt-Kcr: a novel deep learning framework for accurate prediction of lysine crotonylation sites based on learning embedding features and attention architectureZutan Li, Jingya Fang, Shining Wang, et al.
Immunity, Inflammation and Disease|July 28, 2023
The correlation between Th17/Treg immune dysregulation and the disease severity in chronic spontaneous urticaria patientsXiaojing Yang, Leigang Chen, Shining Wang, et al.
British Journal of Clinical Pharmacology|April 10, 2021
Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjectsShining Wang, Grace Chen, Emilio Merlo Pich, et al.
Pageof 4